HRA Pharma Rare Diseases has named AllianceRx Walgreens Prime as its exclusive pharmacy distributor for two…
Articles by David Melamed, PhD
Isturisa (osilodrostat) oral treatment for Cushing’s disease patients is now fully available to be sold and distributed…
Recordati Rare Diseases announced that it has officially acquired marketing rights in Europe for the Cushing’s treatment Isturisa (osilodrostat), enabling…
People with Cushing’s syndrome who undergo surgery to remove one or both adrenal glands experience a persistent decrease in…
Secretion of multiple hormones, high morning cortisol levels, higher tumor grade, and diabetes are all significantly associated with a…